Primary localized amyloidosis of the bladder: a case of AL (lambda) amyloid protein and combination therapy using dimethyl sulfoxide and cepharanthin

Urol Int. 1992;48(2):228-31. doi: 10.1159/000282340.

Abstract

We report a case of primary localized amyloidosis of the bladder with amyloid deposits which was characterized as being of immunoglobulin light chain origin (AL) including lambda type (A lambda) and P component (AP) using the KMnO4 pretreatment method and immunohistochemical procedures. The patient was treated successfully with intravesical dimethyl sulfoxide instillation and oral administration of high-dose cepharanthin after transurethral resection. Combination therapy with dimethyl sulfoxide and cepharanthin was shown to be useful for primary localized amyloidosis of the bladder.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Alkaloids / therapeutic use*
  • Amyloid / analysis*
  • Amyloidosis / drug therapy*
  • Amyloidosis / metabolism
  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Benzylisoquinolines
  • Dimethyl Sulfoxide / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Urinary Bladder / chemistry
  • Urinary Bladder Diseases / drug therapy*
  • Urinary Bladder Diseases / metabolism

Substances

  • Alkaloids
  • Amyloid
  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Benzylisoquinolines
  • amyloid protein AL
  • cepharanthine
  • Dimethyl Sulfoxide